Screener
Core Laboratories CLB EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Core Laboratories in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Core Laboratories’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 6:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-198109
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| EARNINGS PER SHARE INFORMATION: | ||
| Basic earnings (loss) per share | $(0.02) | — |
| Basic earnings (loss) per share attributable to Core Laboratories Inc. | $(0.02) | — |
| Diluted earnings (loss) per share | $(0.02) | — |
| Diluted earnings (loss) per share attributable to Core Laboratories Inc. | $(0.02) | — |
| WEIGHTED AVERAGE COMMON SHARES OUTSTANDING: | ||
| Basic | 46,073 | 46,773 |
| Assuming dilution | 46,073 | 46,773 |
Item 1. Financial Statements
FAQ
- What is Core Laboratories's EPS (diluted)?
- Core Laboratories (CLB) reported EPS (diluted) of -$0.02 in Q1 2026.
- What is the long-term trend for Core Laboratories's EPS (diluted)?
- Over 4 years (2021 to 2025), Core Laboratories's EPS (diluted) has grown at a 10.7% compound annual growth rate (CAGR), from $0.42 to $0.63.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Core Laboratories's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude